Record Financial Performance in 2025
Company reported a record year with record-breaking sales margins, earnings per share, and free cash flow; Q4 adjusted EPS grew 15% and full-year operating income margin reached 18%, up 150 basis points year-over-year.
Organic Sales, Pricing, and Volume Momentum
Organic sales grew 3% in Q4 driven by 3% value pricing and positive volume growth; underlying volume growth improved to ~2% and core businesses (ex-basic industries/paper and distributor inventory effects) delivered mid-single-digit organic growth.
Operating Income and Margin Expansion
Organic operating income grew 12% in Q4 with organic OI margin expanding ~140 basis points to 18.5% (quarter); management expects OI margin to expand another 100–150 basis points in 2026 to above 19% and OI growth of 14–16% for the year.
2026 Guidance — Continued Growth and EPS Upside
Management guided to 3%–4% organic sales growth in 2026 (accelerating through the year), reported sales growth of 7%–9% including Ovivo, and EPS growth of 12%–15% (noting an Ovivo non-cash amortization headwind included).
One Ecolab Cost Savings Upside
Achieved more than $100 million of SG&A savings in 2025 and increased the One Ecolab savings target to $325 million by 2027 (previously raised to $225 million), with program cited as a key driver of SG&A leverage and margin expansion.
Ovivo Acquisition and Global High‑Tech Momentum
Closed Ovivo Electronics earlier than expected (~$500M scale business), which strengthens ultra-pure/circular water capability for semiconductor fabs; global high‑tech including fabs and data center cooling described as a roughly $1B opportunity growing at strong double-digit rates with high margins and early new-fab wins.
Growth Engines and Digital Expansion
Growth engines (including Ovivo) now ~20% of portfolio and expected to grow double digits in 2026; Ecolab Digital reached nearly $400 million in annual sales and grew more than 20% in 2025, with continued heavy investment and pipeline (>25% of innovation pipeline digital).
Strong Segment Performance Across Key Areas
Food & Beverage acceleration to 5%; Pest Elimination and Life Sciences each accelerated to 7%; Specialty grew 7% and continued to gain share; institutional (INS) underlying growth excluding distributor inventory disruption was consistent (INS ex-distribution ~4%).